Ongoing studies into the cognitive deficits and potential treatments of Alzheimer's Disease are an important part of the clinical research program of the Behavioral Neurology Unit. We have recently completed a study of anti-inflammatory medication in Alzheimer's Disease, as well as a study using a novel MRI approach to diagnosing subtle brain changes associated with early Alzheimer's Disease. Research using new pharmacologic agents is anticipated to occur in the near future.